Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
27.77
+0.02 (0.07%)
May 13, 2025, 3:00 PM CST
Yifeng Pharmacy Chain Revenue
Yifeng Pharmacy Chain had revenue of 6.01B CNY in the quarter ending March 31, 2025, with 0.64% growth. This brings the company's revenue in the last twelve months to 24.10B, up 3.47% year-over-year. In the year 2024, Yifeng Pharmacy Chain had annual revenue of 24.06B with 6.53% growth.
Revenue (ttm)
24.10B
Revenue Growth
+3.47%
P/S Ratio
1.40
Revenue / Employee
602.24K
Employees
40,018
Market Cap
33.64B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 24.06B | 1.47B | 6.53% |
Dec 31, 2023 | 22.59B | 2.70B | 13.59% |
Dec 31, 2022 | 19.89B | 4.56B | 29.75% |
Dec 31, 2021 | 15.33B | 2.18B | 16.60% |
Dec 31, 2020 | 13.14B | 2.87B | 27.91% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |